Biocure Technology Inc. (CSE:CURE.X)
Canada · Delayed Price · Currency is CAD 0.0350
0.00 (0.00%)
At close: Feb 26, 2026
Biocure Technology Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
707.25K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green River Gold | 27.00K |
| SBD Capital | 10.24K |
| Cult Food Science | 5.38K |
| Credissential | 2.50K |
| Planet Based Foods Global | -356.97K |
| Digital Asset Technologies | -1.86M |
Biocure Technology News
- 1 year ago - CSE Bulletin: Consolidation - Biocure Technology Inc. (CURE.X) - Newsfile Corp
- 2 years ago - Atriva Therapeutics Announces Exclusive Letter Agreement for Reverse Takeover Transaction with Biocure Technology - GlobeNewsWire
- 2 years ago - Biocure Technology Inc. Enters into Exclusive Letter Agreement to Acquire Atriva Therapeutics GmbH in Reverse Takeover Transaction - Newsfile Corp
- 4 years ago - Biocure Corporate Update - Newsfile Corp
- 4 years ago - Biocure Corporate Update and Financing - Newsfile Corp
- 5 years ago - Biocure Technology Inc. Announces Focus on its own CAR T-cell Therapy Targeting Chronic Lymphocytic Leukemia ("CLL") and Solid Tumor Cancers and Intent to Apply for Patents - Newsfile Corp
- 5 years ago - BioCure Technology Inc. Lists on the Frankfurt Stock Exchange and Completion of Issuer Sponsored Research Report - Newsfile Corp
- 5 years ago - BioCure Technology Inc. Announces New President, Appointment of Capital Markets Advisor and Grant of Stock Options - Newsfile Corp